Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.
Ariane J Marelli, Raluca Ionescu-Ittu, Andrew S Mackie...
https://pubmed.ncbi.nlm.nih.gov/24944314Actively Recruiting
Led by Anne Gallagher · Updated on 2024-11-29
24
Participants Needed
2
Research Sites
21 weeks
Total Duration
A
Anne Gallagher
Lead Sponsor
C
Centre Universitaire de Santé McGill
Collaborating Sponsor
This research aims to evaluate the feasibility of a parent-child yoga intervention designed to reduce attention deficits in children aged 4 to 6 years with congenital heart disease (CHD). Children with CHD often face neurodevelopmental challenges, including a higher risk of attention deficit hyperactivity disorder (ADHD). This study is a preliminary step before conducting a larger randomized controlled trial (RCT) to test the effectiveness of this intervention in improving attention and long-term academic and psychosocial outcomes for these children and their families. The study is a single-blind, two-center, two-arm randomized feasibility trial involving 24 parent-child pairs. Participants will be randomly assigned in a 2:1 ratio to either an 8-week parent-child yoga program plus standard clinical care or standard clinical care alone with a waitlist option for yoga after the study. The yoga sessions last 45 minutes each week and include active and calming parts embedded in stories suitable for the child's developmental level. Parents and children will also be encouraged to practice 5-minute at-home exercises three times a week throughout the 8-week period and continue up to a 6-month follow-up. Participants will undergo three neurodevelopmental assessments: before the intervention, immediately after, and six months later. The study will monitor recruitment, dropout, and adherence rates; acceptability of randomization; variation in yoga delivery; and data completeness. These measurements will help determine the feasibility of the procedures and inform the sample size for the future full-scale RCT. Overall participation spans about eight months including the intervention and follow-up periods.
CONDITIONS
A Parent-child Yoga Intervention for Reducing Attention Deficits in Children with Congenital Heart Disease: a Feasibility Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo standardized interdisciplinary neurodevelopmental assessments before starting the intervention.
1 visit (in-person)
Duration - 8 weeks
Participants in the yoga group take part in an 8-week parent-child yoga program alongside standard clinical care, including weekly 45-minute yoga sessions and home exercises practiced at least 3 times per week.
Weekly visits for 8 weeks plus home exercises 3 times per week
Duration - 1 day
Participants undergo standardized neurodevelopmental assessments immediately after the 8-week intervention or observation period.
1 visit (in-person)
Duration - 1 day
Participants complete standardized neurodevelopmental assessments 6 months after the intervention to evaluate long-term effects.
1 visit (in-person)
Total: 2 locations
1
Centre hospitalier universitaire Sainte-Justine
Montreal, Quebec, Canada, H3T1C5
Actively Recruiting
2
Centre universtaire de santé McGill
Montreal, Quebec, Canada, H4A3J1
Actively Recruiting
A
Anne Gallagher, PhD
M
Marie-Noëlle Simard, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ariane J Marelli, Raluca Ionescu-Ittu, Andrew S Mackie...
https://pubmed.ncbi.nlm.nih.gov/24944314Chia-Ching Wang, Wen-Chin Weng, Ling-Yin Chang...
https://pubmed.ncbi.nlm.nih.gov/32394091Charles Lepage, Isabelle Gaudet, Amélie Doussau...
https://pubmed.ncbi.nlm.nih.gov/36683797Isabelle Gaudet, Natacha Paquette, Catherine Bernard...
https://pubmed.ncbi.nlm.nih.gov/34454950Amy J Lisanti
https://pubmed.ncbi.nlm.nih.gov/29991369Catherine K Mak, Koa Whittingham, Roslyn N Boyd
https://pubmed.ncbi.nlm.nih.gov/30712729Lindy L Weaver, Amy R Darragh
https://pubmed.ncbi.nlm.nih.gov/26565100Samantha C L Cohen, Danielle J Harvey, Rebecca H Shields...
https://pubmed.ncbi.nlm.nih.gov/29538185Marie-Noëlle Simard, Charles Lepage, Isabelle Gaudet...
https://pubmed.ncbi.nlm.nih.gov/37848299